1. Phase I study of tirabrutinib (ONO‐4059/GS‐4059) in patients with relapsed or refractory B‐cell malignancies in Japan. Issue 5 (28th March 2019) Authors: Munakata, Wataru; Ando, Kiyoshi; Hatake, Kiyohiko; Fukuhara, Noriko; Kinoshita, Tomohiro; Fukuhara, Suguru; Shirasugi, Yukari; Yokoyama, Masahiro; Ichikawa, Satoshi; Ohmachi, Ken; Gion, Naokazu; Aoi, Arata; Tobinai, Kensei Journal: Cancer science Issue: Volume 110:Issue 5(2019) Page Start: 1686 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗